Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Non-allergic angioedema: update].

L Bouillet1, D Ponard, C Drouet

  • 1Service de médecine interne, pavillon Dominique-Villars, département pluridisciplinaire de médecine, CHU, BP 217, 38043 Grenoble, France. LBouilletClaveyrolas@chu-grenoble.fr

La Revue De Medecine Interne
|July 11, 2002
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

[An exceptional case of disseminated cystic echinococcosis].

La Revue de medecine interne·2026
Same author

The International Guideline for the Definition, Classification, Diagnosis and Management of Urticaria.

Allergy·2026
Same author

Distribution of epithelial endoplasmic reticulum stress-related proteins in adult and pediatric Crohn's disease: Association with inflammation and fibrosis.

Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver·2025
Same author

Effectiveness of Aerobic Treadmill Training on Walking Distance in Patients with Multiple Sclerosis with Moderate Disability: A Randomised Controlled Multicentre Trial.

NeuroRehabilitation·2025
Same author

Patients with multiple sclerosis and low disability display cautious rotational behavior during gait initiation.

Clinical biomechanics (Bristol, Avon)·2025
Same author

Early screening for chronic liver disease: impact of a FIB-4 first integrated care pathway to identify patients with significant fibrosis.

Scientific reports·2024
Same journal

[Abdominal pain, fever and arthralgia in a 49-year-old woman].

La Revue de medecine interne·2026
Same journal

[Cardiorespiratory functional disorders: A transnosologic approach].

La Revue de medecine interne·2026
Same journal

[Diagnostic evaluation for suspected polycythemia].

La Revue de medecine interne·2026
Same journal

Heart involvements in systemic sclerosis beyond pulmonary hypertension: From conduction, rhythm and function defects to coronary artery disease.

La Revue de medecine interne·2026
Same journal

[Acute intermittent porphyria: When diagnostic errance jeopardizes patient health].

La Revue de medecine interne·2026
Same journal

Autosomal dominant polycystic kidney disease: Current perspectives in 2026.

La Revue de medecine interne·2026
See all related articles

Nonallergic angioedema diagnosis and treatment are challenging. Hereditary angioneurotic edema, often linked to C1Inhibitor deficiency, requires specialized care, while other forms may benefit from plasmin and bradykinin inhibitors.

Area of Science:

  • Immunology
  • Pharmacology

Context:

  • Nonallergic isolated angioedema presents diagnostic and therapeutic challenges.
  • Hereditary angioneurotic edema (HANE) associated with C1 inhibitor (C1Inh) deficiency is a primary concern.
  • Other angioedema forms include estrogen-related, secondary to pathologies, and drug-induced (e.g., ACE inhibitors).

Purpose:

  • To highlight the diagnostic and therapeutic complexities of nonallergic angioedema.
  • To emphasize the priority of investigating C1Inh-related angioedema due to specific management needs.
  • To review differential diagnoses and contributing factors in angioedema.

Summary:

  • Uncontrolled contact system activation is implicated in most angioedema cases.
  • Tranexamic acid demonstrates efficacy by modulating contact system activation.

Related Experiment Videos

  • Future therapeutic strategies focus on developing plasmin and bradykinin inhibitors.

    • Impact:

    • Improved understanding of angioedema pathophysiology.
    • Guidance for clinical management of diverse angioedema presentations.
    • Informs future drug development for refractory angioedema.